Skip to main content

Peer Review reports

From: Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial

Original Submission
26 Oct 2022 Submitted Original manuscript
24 Nov 2022 Reviewed Reviewer Report
25 Nov 2022 Reviewed Reviewer Report
28 Nov 2022 Reviewed Reviewer Report - Shuo Fang
28 Jan 2023 Author responded Author comments - Yong Li
Resubmission - Version 2
28 Jan 2023 Submitted Manuscript version 2
1 Feb 2023 Reviewed Reviewer Report
5 Feb 2023 Reviewed Reviewer Report
16 Feb 2023 Author responded Author comments - Yong Li
Resubmission - Version 3
16 Feb 2023 Submitted Manuscript version 3
Publishing
22 Feb 2023 Editorially accepted
8 Mar 2023 Article published 10.1186/s12916-023-02804-y

You can find further information about peer review here.

Back to article page